1,152
Views
27
CrossRef citations to date
0
Altmetric
Review Articles

Treating organophosphates poisoning: management challenges and potential solutions

& ORCID Icon
Pages 764-779 | Received 07 Jul 2020, Accepted 11 Oct 2020, Published online: 13 Nov 2020

References

  • Abou-Donia MB, Siracuse B, Gupta N, Sobel Sokol A. 2016. Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review. Crit Rev Toxicol. 46(10):845–875.
  • Afify T, El-Barrany UM, Elshikhiby H, Adly M, Fathy S. 2016. Effect of intravenous magnesium sulphate on mortality rate in acute organophosphate toxicity. Egypt J Forensic Sci Appl Toxicol. 16(1):11–15.
  • Agency for Toxic Substances and Disease Registry. 2010. Cholinesterase inhibitors – environmental medicine & environmental health education. Atlanta (GA): ATSDR.
  • Ali R, Jain GK, Iqbal Z, Talegaonkar S, Pandit P, Sule S, Malhotra G, Khar RK, Bhatnagar A, Ahmad FJ. 2009. Development and clinical trial of nano-atropine sulfate dry powder inhaler as a novel organophosphorous poisoning antidote. Nanomed Nanotechnol, Biol Med. 5(1):55–63.
  • Anju N, Rh SR, Nalini P. 2010. Comparison of efficacy and safety of atropine sulphate and glycopyrrolate in the treatment of organophosphorus poisoning. Ind J Pharm Pract. 3(1):43–46.
  • Aodah A, Bafail RS, Rawas-Qalaji M. 2017. Formulation and evaluation of fast-disintegrating sublingual tablets of atropine sulfate: the effect of tablet dimensions and drug load on tablet characteristics. AAPS PharmSciTech. 18(5):1624–1633.
  • Aodah A, Rawas-Qalaji M, Bafail R, Rawas-Qalaji M. 2019. Effect of fast-disintegrating tablets’ characteristics on the sublingual permeability of atropine sulfate for the potential treatment of organophosphates toxicity. AAPS PharmSciTech. 20(6):229.
  • Arendse R, Irusen E. 2009. An atropine and glycopyrrolate combination reduces mortality in organophosphate poisoning. Hum Exp Toxicol. 28(11):715–720.
  • ATNAA Auto-Injector [Package Insert]. 2017. Columbia (MD): Meridian Medical Technologies; [accessed 2020 Oct 22]. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=596c7a8f-27cd-4de2-9491-476f43570b8b&type=display.
  • Atropen® Auto-Injector [Package Insert]. 2017. Columbia (MD): Meridian Medical Technologies; [accessed 2020 Oct 22]. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=e2d4307d-da8f-49f5-aac0-02355dd9ffb7&type=display.
  • Bafail R, Rawas-Qalaji M, Rawas-Qalaji M, Aodah A. 2019. Effect of the filler grade on the characteristics and the sublingual permeability of atropine sulfate fast disintegrating sublingual tablets. Drug Dev Ind Pharm. 45(10):1617–1623.
  • Bajgar J. 2010. Optimal choice of acetylcholinesterase reactivators for antidoral treatment of nerve agent intoxication. Acta Med. 53(4):207–211.
  • Balali-Mood M, Balali-Mood B, Balali-Mood K. 2016. Nerve agents. In: Critical care toxicology. Cham (Switzerland): Springer International Publishing; p. 1–28.
  • Balali-Mood M, Saber H. 2012. Recent advances in the treatment of organophosphorous poisonings. Iran J Med Sci. 37(2):74–91.
  • Barth SK, Dursa EK, Bossarte RM, Schneiderman AI. 2017. Trends in brain cancer mortality among U.S. Gulf War veterans: 21 year follow-up. Cancer Epidemiol. 50(A):22–29.
  • Basher A, Rahman SH, Ghose A, Arif SM, Faiz MA, Dawson AH. 2013. Phase II study of magnesium sulfate in acute organophosphate pesticide poisoning. Clin Toxicol. 51(1):35–40.
  • Bhandarkar AA. 2014. Efficacy of atropine alone and with glycopyrrolate combination in organophosphate poisoning. Value Health. 17(7):A750–A751.
  • Bird S. 2020. Organophosphate and carbamate poisoning. In: Traub SJ, Grayzel J, editors. UpToDate. Waltham (MA): UpToDate. [accessed 2020 Oct 22]. https://www.uptodate.com/contents/organophosphate-and-carbamate-poisoning?search=organophosphate-and-carbamate-poisoning%22&source=search_result&selectedTitle=1∼150&usage_type=default&display_rank=1
  • Bohnert S, van den Berg RM, Mikler J, Klaassen SD, Joosen MJA. 2020. Pharmacokinetics of three oximes in a guinea pig model and efficacy of combined oxime therapy. Toxicol Lett. 324:86–94.
  • Brady S, Siegel G, Albers RW, Price D (Eds.). 2011. Acetylcholine. In: Basic neurochemistry. Waltham (MA): Academic Press; p. 258–282.
  • Brimijoin S, Chen VP, Pang Y-P, Geng L, Gao Y. 2016. Physiological roles for butyrylcholinesterase: a BChE-ghrelin axis. Chem Biol Interact. 259(B):271–275.
  • Brooks J, Erickson TB, Kayden S, Ruiz R, Wilkinson S, Burkle FM. 2018. Responding to chemical weapons violations in Syria: legal, health, and humanitarian recommendations. Confl Health. 12(1):12–17.
  • Brvar M, Chan MY, Dawson AH, Ribchester RR, Eddleston M. 2018. Magnesium sulfate and calcium channel blocking drugs as antidotes for acute organophosphorus insecticide poisoning – a systematic review and meta-analysis. Clin Toxicol. 56(8):725–736.
  • Buckley NA, Eddleston M, Li Y, Bevan M, Robertson J. 2011. Oximes for acute organophosphate pesticide poisoning. Cochrane Database Syst Rev. (2):CD005085.
  • Caisberger F, Pejchal J, Misik J, Kassa J, Valis M, Kuca K. 2018. The benefit of combinations of oximes for the ability of antidotal treatment to counteract sarin-induced brain damage in rats. BMC Pharmacol Toxicol. 19(1):35.
  • Carullo P, Cetrangolo G, Mandrich L, Manco G, Febbraio F. 2015. Fluorescence spectroscopy approaches for the development of a real-time organophosphate detection system using an enzymatic sensor. Sensors. 15(2):3932–3951.
  • Casey Laizure S, Herring V, Hu Z, Witbrodt K, Parker RB. 2013. The role of human carboxylesterases in drug metabolism: have we overlooked their importance? Pharmacother. Pharmacotherapy. 33(2):210–222.
  • Chad L, Ben-Shoshan M, Asai Y, Cherkaoui S, Alizadehfar R, St-Pierre Y, Harada L, Allen M, Clarke A. 2013. A majority of parents of children with peanut allergy fear using the epinephrine auto-injector. Allergy. 68(12):1605–1609.
  • Chai PR, Hayes BD, Erickson TB, Boyer EW. 2018. Novichok agents: a historical, current, and toxicological perspective. Toxicol Commun. 2(1):45–48.
  • Chambers JE, Chambers HW, Funck KE, Meek EC, Pringle RB, Ross MK. 2016. Efficacy of novel phenoxyalkyl pyridinium oximes as brain-penetrating reactivators of cholinesterase inhibited by surrogates of sarin and VX. Chem Biol Interact. 259(B):154–159.
  • Corcoran TE, Venkataramanan R, Hoffman RM, George MP, Petrov A, Richards T, Zhang S, Choi J, Gao YY, Oakum CD, et al. 2013. Systemic delivery of atropine sulfate by the microdose dry-powder inhaler. J Aerosol Med Pulm Drug Deliv. 26(1):46–55.
  • Costa LG. 2018. Organophosphorus Compounds at 80: some old and new issues. Toxicol Sci. 162(1):24–35.
  • Costanzi S, Machado J-H, Mitchell M. 2018. Nerve agents: what they are, how they work, how to counter them. ACS Chem Neurosci. 9(5):873–885.
  • Dail MB, Leach CA, Meek EC, Olivier AK, Pringle RB, Green CE, Chambers JE. 2019. Novel brain-penetrating oxime acetylcholinesterase reactivators attenuate organophosphate-induced neuropathology in the rat hippocampus. Toxicol Sci. 169(2):465–474.
  • Dhanarisi J, Shihana F, Harju K, Mohamed F, Verma V, Shahmy S, Vanninen P, Kostiainen O, Gawarammana I, Eddleston M. 2020. A pilot clinical study of the neuromuscular blocker rocuronium to reduce the duration of ventilation after organophosphorus insecticide poisoning. Clin Toxicol. 58(4):254–261.
  • Dong H, Weng Y-B, Zhen G-S, Li F-J, Jin A-C, Liu J. 2017. Clinical emergency treatment of 68 critical patients with severe organophosphorus poisoning and prognosis analysis after rescue. Medicine. 96(25):e7237.
  • Eddleston M. 2019. Novel clinical toxicology and pharmacology of organophosphorus insecticide self-poisoning. Annu Rev Pharmacol Toxicol. 59(1):341–360.
  • Eddleston M, Chowdhury FR. 2016. Pharmacological treatment of organophosphorus insecticide poisoning: the old and the (possible) new. Br J Clin Pharmacol. 81(3):462–470.
  • Eisenkraft A, Falk A. 2016. Possible role for anisodamine in organophosphate poisoning. Br J Pharmacol. 173(11):1719–1727.
  • El-Ebiary A, Gad S, Wahdan A, El-Mehallawi I. 2016. Clonidine as an adjuvant in the management of acute poisoning by anticholinesterase pesticides. Hum Exp Toxicol. 35(4):371–376.
  • Emergent BioSolutions. 2017. Emergent BioSolutions awarded U.S. department of state contract valued at up to $25 million to supply nerve agent antidote auto-injector. Gaithersburg (MD): Emergent BioSolutions. https://www.globenewswire.com/news-release/2017/10/04/1140537/0/en/Emergent-BioSolutions-Awarded-U-S-Department-of-State-Contract-Valued-at-Up-to-25-Million-to-Supply-Nerve-Agent-Antidote-Auto-Injector.html
  • Food and Drug Administration. 2019. Products approved for chemical emergencies. [accessed 2020 Oct 22]. https://www.fda.gov/drugs/bioterrorism-and-drug-preparedness/products-approved-chemical-emergencies
  • Garcia GE, Campbell AJ, Olson J, Moorad-Doctor D, Morthole VI. 2010. Novel oximes as blood–brain barrier penetrating cholinesterase reactivators. Chem Biol Interact. 187(1–3):199–206.
  • Gorecki L, Gerlits O, Kong X, Cheng X, Blumenthal DK, Taylor P, Ballatore C, Kovalevsky A, Radić Z. 2020. Rational design, synthesis, and evaluation of uncharged, “smart” bis-oxime antidotes of organophosphate-inhibited human acetylcholinesterase. J Biol Chem. 295(13):4079–4092.
  • Guerlain S, Hugine A, Wang L. 2010. A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference. Ann Allergy, Asthma Immunol. 104(2):172–177.
  • Gupta R. 2005. Classification and uses of organophosphates and carbamates. In: Gupta R, editor. Toxicology of organophosphate and carbamate compounds. Burlington (MA): Elsevier Academic Press; p. 5–24.
  • Harsha SJ, Prabhu SNC, Raheja RM, Ranjan OR, 2017. Role of intravenous magnesium sulphate in predicting outcomes of ICU in acute organophosphate poisoning. Ind J Emergency Med. 3(2):231–235.
  • Indu TH, Raja D, Manjunatha B, Ponnusankar S. 2016. Can galantamine act as an antidote for organophosphate poisoning? A review. Indian J Pharm Sci. 78(4):428–435.
  • Iyer R, Iken B, Leon A. 2015. Developments in alternative treatments for organophosphate poisoning. Toxicol Lett. 233(2):200–206.
  • Jacob RB, Michaels KC, Anderson CJ, Fay JM, Dokholyan NV. 2016. Harnessing nature’s diversity: discovering organophosphate bioscavenger characteristics among low molecular weight proteins. Sci Rep. 6(1):37175.
  • Jamshidi F, Yazdanbakhsh A, Jamalian M, Khademhosseini P, Ahmadi K, Sistani A, Jokar A. 2018. Therapeutic effect of adding magnesium sulfate in treatment of organophosphorus poisoning. Open Access Maced J Med Sci. 6(11):2051–2056.
  • Jiang S, Ma B, Liu C, Wang R. 2019. Clinical efficacy of intravenous infusion of atropine with micropump in combination with hemoperfusion on organophosphorus poisoning. Saudi J Biol Sci. 26(8):2018–2021.
  • Joosen MJA, Vester SM, Hamelink J, Klaassen SD, van den Berg RM. 2016. Increasing nerve agent treatment efficacy by P-glycoprotein inhibition. Chem Biol Interact. 259(B):115–121.
  • Karasova JZ, Stodulka P, Pohanka M, Kuca K. 2010. In vitro screening of blood-brain barrier penetration of monoquaternary acetylcholinesterase reactivators. Anal Lett. 43(9):1516–1524.
  • Kassa J, Karasova JZ, Pavlikova R, Misik J, Caisberger F, Bajgar J. 2009. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice. J Appl Toxicol. 30(2):120–124.
  • Kobrlova T, Korabecny J, Soukup O. 2019. Current approaches to enhancing oxime reactivator delivery into the brain. Toxicology. 423:75–83.
  • Krishnan JKS, Arun P, Appu AP, Vijayakumar N, Figueiredo TH, Braga MFM, Baskota S, Olsen CH, Farkas N, Dagata J, et al. 2016. Intranasal delivery of obidoxime to the brain prevents mortality and CNS damage from organophosphate poisoning. Neurotoxicology. 53:64–73.
  • Kuca K, Musilek K, Jun D, Zdarova-Karasova J, Nepovimova E, Soukup O, Hrabinova M, Mikler J, Franca TCC, Da Cunha EFF, et al. 2018. A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase. BMC Pharmacol Toxicol. 19(1):8.
  • Kumar A, Margekar SL, Margekar P, Margekar V. 2018. Recent advances in management of organophosphate & carbamate poisoning. Indian J Med Spec. 9(3):154–159.
  • Kumar P, Vijayaraghavan RMS. 2001. Efficacy of atropine nasal aerosol spray against organophosphorus poisoning. Indian J Pharmacol. 33(6):431–436.
  • Lavon O, Eisenkraft A, Blanca M, Raveh L, Ramaty E, Krivoy A, Atsmon J, Grauer E, Brandeis R. 2015. Is rivastigmine safe as pretreatment against nerve agents poisoning? A pharmacological, physiological and cognitive assessment in healthy young adult volunteers. Neurotoxicology. 49:36–44.
  • Lewine JD, Weber W, Gigliotti A, McDonald JD, Doyle-Eisele M, Bangera N, Paulson K, Magcalas C, Hamilton DA, Garcia E, et al. 2018. Addition of ketamine to standard-of-care countermeasures for acute organophosphate poisoning improves neurobiological outcomes. Neurotoxicology. 69:37–46.
  • Liu H-X, Liu C-F, Yang W-H. 2015. Clinical study of continuous micropump infusion of atropine and pralidoxime chloride for treatment of severe acute organophosphorus insecticide poisoning. J Chinese Med Assoc. 78(12):709–713.
  • Lorke DE, Petroianu GA. 2019. Reversible cholinesterase inhibitors as pretreatment for exposure to organophosphates. A review. J Appl Toxicol. 39(1):101–116.
  • Mata DG, Rezk PE, Sabnekar P, Cerasoli DM, Chilukuri N. 2014. Investigation of evolved paraoxonase-1 variants for prevention of organophosphorous pesticide compound intoxication. J Pharmacol Exp Ther. 349(3):549–558.
  • Mohammad FK, Mousa YJ, Al-Zubaidy MHI, Alias AS. 2012. Assessment of diphenhydramine effects against acute poisoning induced by the organophosphate insecticide dichlorvos in chicks. Hum Vet Med. 4(1):6–13.
  • Mohapatra S, Rath N. 2014. Mania following organophosphate poisoning. J Neurosci Rural Pract. 5(1):86–87.
  • Moshiri M, Darchini-Maragheh E, Balali-Mood M. 2012. Advances in toxicology and medical treatment of chemical warfare nerve agents. DARU J Pharm Sci. 20(1):81.
  • Motawei SM, Elbiomy AA. 2017. Sodium bicarbonate and n-acetyl cysteine in treatment of organophosphorus poisoning cases: a randomized controlled clinical trial. Toxicol Open Access. 3:123.
  • Mousa Y. 2009. Effect of chlorpheniramine on acute dichlorvos poisoning in chicks. Iraqi J Vet Sci. 23(2):35–43.
  • Muñoz-Quezada MT, Lucero BA, Iglesias VP, Muñoz MP, Cornejo CA, Achu E, Baumert B, Hanchey A, Concha C, Brito AM, et al. 2016. Chronic exposure to organophosphate (OP) pesticides and neuropsychological functioning in farm workers: a review. Int J Occup Environ Health. 22(1):68–79.
  • Myers TM. 2019. Human plasma-derived butyrylcholinesterase is behaviorally safe and effective in cynomolgus macaques (Macaca fascicularis) challenged with soman. Chem Biol Interact. 308:170–178.
  • Myhrer T, Mariussen E, Enger S, Aas P. 2015. Supralethal poisoning by any of the classical nerve agents is effectively counteracted by procyclidine regimens in rats. Neurotoxicology. 50:142–148.
  • Nurulain SM, Ojha S, Shafiullah M, Khan N, Oz M, Sadek B. 2015. Protective effects of the antihistamine promethazine aginst acute paraxon-methyl and dicrotophos toxicity in adult rats. Int J Clin Exp Med. 8(10):17891–17901.
  • Ojha S, Sharma C, Nurulain SM. 2014. Antihistamines: promising antidotes of organophosphorus poisoning. MMSL. 83(3):97–103.
  • Okolotowicz KJ, Dwyer M, Smith E, Cashman JR. 2014. Preclinical studies of noncharged oxime reactivators for organophosphate exposure. J Biochem Mol Toxicol. 28(1):23–31.
  • Park J-H, Lee J-Y, Kim K-T, Joe H-E, Cho H-J, Shin Y-K, Kim D-D. 2018. Physostigmine-loaded liposomes for extended prophylaxis against nerve agent poisoning. Int J Pharm. 553(1–2):467–473.
  • Pashirova TN, Zueva IV, Petrov KA, Babaev VM, Lukashenko SS, Rizvanov IK, Souto EB, Nikolsky EE, Zakharova LY, Masson P, et al. 2017. Nanoparticle-delivered 2-PAM for rat brain protection against paraoxon central toxicity. ACS Appl Mater Interfaces. 9(20):16922–16932.
  • Peng A, Meng F-Q, Sun L-F, Ji Z-S, Li Y-H. 2004. Therapeutic efficacy of charcoal hemoperfusion in patients with acute severe dichlorvos poisoning. Acta Pharmacol Sin. 25(1):15–21.
  • Perera PMS, Jayamanna SF, Hettiarachchi R, Abeysinghe C, Karunatilake H, Dawson AH, Buckley NA. 2009. A phase II clinical trial to assess the safety of clonidine in acute organophosphorus pesticide poisoning. Trials. 10(1):73.
  • Peter JV, Sudarsan T, Moran J. 2014. Clinical features of organophosphate poisoning: a review of different classification systems and approaches. Indian J Crit Care Med. 18(11):735–745.
  • Petroianu GA, Hasan MY, Nurulain SM, Arafat K, Sheen R, Nagelkerke N. 2007. Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine. Toxicol Appl Pharmacol. 219(2–3):235–240.
  • Phospholine Iodide® Ophthalmic [Package Insert]. 2018. Philadelphia (PA): Wyeth Pharmaceuticals LLC; [accessed 2020 Oct 22]. http://labeling.pfizer.com/showlabeling.aspx?id=128.
  • Pralidoxime Chloride Auto-Injector [Package Insert]. 2016. Columbia (MD): Meridian Medical Technologies; [accessed 2020 Oct 22]. https://www.meridianmeds.com/sites/default/files/pralidoxime_chloride_uspi_2016.pdf.
  • Prince BT, Mikhail I, Stukus DR. 2018. Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities. J Asthma Allergy. 11:143–151.
  • Priyendu A, Vandana KE, Nilima, Varma M, Prabhu N, Rahim AA, Nagappa AN. 2017. Antibiotic prophylaxis in organophosphorus poisoning: a study of health and economic outcomes. Saudi Pharm J. 25(3):332–336.
  • Pyridostigmine Bromide Tablets, USP [Package Insert]. 2003. Philadelphia (PA): Defense Supply Center; [accessed 2020 Oct 22]. https://www.fda.gov/media/75559/download.
  • Rajpal S, Mittal G, Sachdeva R, Chhillar M, Ali R, Agrawal SS, Kashyap R, Bhatnagar A. 2009. Development of atropine sulphate nasal drops and its pharmacokinetic and safety evaluation in healthy human volunteers. Environ Toxicol Pharmacol. 27(2):206–211.
  • Rambabu L, Megson IL, Eddleston M. 2020. Does oxidative stress contribute to toxicity in acute organophosphorus poisoning? A systematic review of the evidence. Clin Toxicol. 58(6):437–452.
  • Reddy SD, Reddy DS. 2015. Midazolam as an anticonvulsant antidote for organophosphate intoxication-a pharmacotherapeutic appraisal. Epilepsia. 56(6):813–821.
  • Rice H, Dalton CH, Price ME, Graham SJ, Green AC, Jenner J, Groombridge HJ, Timperley CM. 2015. Toxicity and medical countermeasure studies on the organophosphorus nerve agents VM and VX. Proc Math Phys Eng Sci. 471(2176):20140891.
  • Ring A, Strom BO, Turner SR, Timperley CM, Bird M, Green AC, Chad JE, Worek F, Tattersall JEH. 2015. Bispyridinium compounds inhibit both muscle and neuronal nicotinic acetylcholine receptors in human cell lines (H Ulrich, Ed). PLoS One. 10(8):e0135811.
  • Robb EL, Barker MB. 2020. Organophosphate toxicity. In: StatPearls. Treasure Island (FL): StatPearls Publishing LLC.
  • Roberts DM, Buckley N. 2005. Alkalinisation for organophosphorus pesticide poisoning. Cochrane Database Syst Rev. 1(1):1–17.
  • Roberts J, Routt R. 2013. Organophosphate insecticides. In: Chamberlain K, O’Neal S, editors. Recognition and management of pesticide poisoning. Washington (DC): U.S. Environmental Protection Agency; p. 43–55.
  • Ross SM, McManus IC, Harrison V, Mason O. 2013. Neurobehavioral problems following low-level exposure to organophosphate pesticides: a systematic and meta-analytic review. Crit Rev Toxicol. 43(1):21–44.
  • Sharma K. 2019. Cholinesterase inhibitors as Alzheimer’s therapeutics (Review). Mol Med Rep. 20(2):1479–1487.
  • Stojiljković MP, Škrbić R, Jokanović M, Bokonjić D, Kilibarda V, Vulović M. 2019. Prophylactic potential of memantine against soman poisoning in rats. Toxicology. 416:62–74.
  • Stone R. 2018. How to defeat a nerve agent. Sci. 359(6371):23. doi: 10.1126/science.359.6371.23.
  • Vijayakumar H, Kannan S, Tejasvi C, Duggappa D, Veeranna Gowda K, Nethra S. 2017. Study of effect of magnesium sulphate in management of acute organophosphorous pesticide poisoning. Anesth Essays Res. 11(1):192.
  • Vijayaraghavan R. 2020. Autoinjector device for rapid administration of drugs and antidotes in emergency situations and in mass casualty management. J Int Med Res. 48(5):0300060520926019.
  • Wang W, Chen Q-F, Li Q-B, Wu Y-B, Chen K, Chen B, Wen J-M. 2014. Efficiency of anisodamine for organophosphorus-poisoned patients when atropinization cannot be achieved with high doses of atropine. Environ Toxicol Pharmacol. 37(2):477–481.
  • Whitmore C, Lindsay CD, Bird M, Gore SJ, Rice H, Williams RL, Timperley CM, Green AC. 2020. Assessment of false transmitters as treatments for nerve agent poisoning. Toxicol Lett. 321:21–31.
  • World Health Organization. 2008. Clinical management of acute pesticide intoxication: prevention of suicidal behaviours. Geneva (Switzerland): WHO; No. 978 92 4 159745 6.
  • Wu X, Kuruba R, Reddy DS. 2018. Midazolam-resistant seizures and brain injury after acute intoxication of diisopropylfluorophosphate, an organophosphate pesticide and surrogate for nerve agents. J Pharmacol Exp Ther. 367(2):302–321.
  • Yavuz Y, Yurumez Y, Ciftci IH, Sahin O, Saglam H, Buyukokuroglu M. 2008. Effect of diphenhydramine on myocardial injury caused by organophosphate poisoning. Clin Toxicol. 46(1):67–70.
  • Zdarova Karasova J, Hepnarova V, Andrys R, Lisa M, Jost P, Muckova L, Pejchal J, Herman D, Jun D, Kassa J, et al. 2020. Encapsulation of oxime K027 into cucurbit[7]uril: in vivo evaluation of safety, absorption, brain distribution and reactivation effectiveness. Toxicol Lett. 320:64–72.
  • Zhuang Q, Young A, Callam CS, McElroy CA, Ekici ÖD, Yoder RJ, Hadad CM. 2016. Efforts toward treatments against aging of organophosphorus-inhibited acetylcholinesterase. Ann NY Acad Sci. 1374(1):94–104.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.